Search

everythinglearnresearchcommunity

for

Search:↓

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

PDI helps restore over-bleached hair's strength and structure by attaching special peptides.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

PDGF-BB helps young melanocytes grow but stops mature ones from growing, and it makes melanocytes more specialized.

Progesterone protects brain cells, but Provera does not.

Valproic acid and rapamycin protect hair follicle stem cells from damage by activating a protective pathway.

DPCP is more effective than tretinoin gel for treating severe alopecia.

Valproic acid can cause a rare allergic reaction leading to fluid around the lungs and heart, which is treatable by changing medication.

PLD is an effective and safer alternative for treating breast cancer.

The hydrogel helps heal diabetic wounds by reducing infection and inflammation.

A child with trichothiodystrophy also had autoimmune thyroiditis and anemia, which is a new finding.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Higher 3α,5α-THP levels in the brain may reduce depression in pregnant rats.

Divalproex sodium can cause pleural effusion, which stops when the drug is discontinued.

The thulium laser and PDRN injections effectively improved hair thickness in patients with pattern hair loss.

Diphenylcyclopropenone (DPCP) is effective in treating alopecia areata, with most patients showing significant hair regrowth.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

PPAR β/δ is important for skin health and disease treatment, but more research is needed.

A peptide called DPS-1 helps human scalp cells grow and stimulates hair growth in mice.

A new genetic disorder caused by an ODC1 mutation can be treated with DFMO.

VDDR I and II are genetic disorders affecting vitamin D use, causing rickets, with VDDR I treatable by vitamin D supplements and VDDR II needing high doses and calcium.

Changes in genes FGA, VWF, and ACTG1 may contribute to pemphigus vulgaris.

Anti-epileptic drugs may cause visual and hair side effects due to enzyme inhibition, especially in genetically predisposed individuals.

Valproate can cause hair loss and changes in hair appearance, but may help regrow hair when applied topically.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.